Biobank For MS And Other Demyelinating Diseases

Accelerated Cure Project for Multiple Sclerosis

Status: Active, not recruiting

Conditions: Neuromyelitis Optica; Multiple Sclerosis; Transverse Myelitis; Optic Neuritis; Acute Disseminated Encephalomyelitis

Study type: Observational

Funder types: Other

Identifiers

NCT00445367

ACP-001

Details and patient eligibility

About

To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Enrollment: 3,226 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
• willing to provide up to 110 ml (50 ml for < 18 years old) of blood via venipuncture
• experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

Exclusion criteria

• history of blood borne pathogens
• allogeneic bone marrow transplant
• clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
• weight less than 37 pounds

Trial design

3,226 participants in 2 patient groups

Case

Control